Research Article
Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract
Table 4
A table showing serum lipid levels before and three (3) months after C. membranaceus ethanolic root extract administration at 20 mg t.i.d.
| Parameter | Mean ± SD (before) | Mean ± SD (after) | value |
| TC (mmol/L) | 5.03 ± 1.12 | 5.19 ± 1.15 | 0.423 | TG (mmol/L) | 1.15 ± 0.43 | 1.22 ± 0.56 | 0.518 | HDL (mmol/L) | 0.76 ± 0.33 | 0.88 ± 0.32 | 0.063 | LDL (mmol/L) | 3.74 ± 1.03 | 3.75 ± 1.02 | 0.959 | APO A (g/L) | 1.31 ± 0.45 | 1.51 ± 0.47 | 0.025 | APO B (g/L) | 0.58 ± 0.37 | 0.49 ± 0.13 | 0.222 | APO B/A ratio | 2.81 ± 1.47 | 3.24 ± 1.27 | 0.067 |
|
|
Significance at 95% confidence interval.
|